Clinical Complete Response After Conversion Therapy for Unresectable Hepatocellular Carcinoma: Is Salvage Hepatectomy Necessary?
Jia-Yi Wu, Jun-Yi Wu, De-Yi Liu, Han Li, Shao-Wu Zhuang, Bin Li, Jian-Yin Zhou, Jing-Yao Huang, Zhi-Bo Zhang, Shu-Qun Li, Mao-Lin Yan, Yao-Dong Wang · 2023
Read Clinical Complete Response After Conversion Therapy for Unresectable Hepatocellular Carcinoma: Is Salvage Hepatectomy Necessary? by Jia-Yi Wu, Jun-Yi Wu, De-Yi Liu, Han Li, Shao-Wu Zhuang, Bin Li, Jian-Yin Zhou, Jing-Yao Huang, Zhi-Bo Zhang, Shu-Qun Li, Mao-Lin Yan, Yao-Dong Wang (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10710241.txt.
Description
Jia-Yi Wu and co-authors ask whether patients whose liver cancer vanishes on scans after conversion therapy still need the tumor bed cut out. Some unresectable liver cancers shrink under modern drug combinations until no active tumor can be seen, a clinical complete response. Surgery might lock in the win, or might only add risk.
Seventy-four such patients from seven Chinese cancer centers were compared, forty-five operated and twenty-nine managed without surgery, with statistical matching to balance the groups. Survival and recurrence outcomes test the value of salvage hepatectomy after apparent cure. The answer shapes how aggressively teams should chase a tumor that imaging says is already gone.
Catalog record
| CREATOR | Jia-Yi Wu, Jun-Yi Wu, De-Yi Liu, Han Li, Shao-Wu Zhuang, Bin Li, Jian-Yin Zhou, Jing-Yao Huang, Zhi-Bo Zhang, Shu-Qun Li, Mao-Lin Yan, Yao-Dong Wang |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |